No matching stocks found

Take a short break, or try a different search term.

Try widening your filters, clearing the search, or checking another sector.

“Good screens are built by narrowing the noise, not the signal.”

Plutux

Johnson & Johnson (JNJ) CEO profile

Systems Boards Journals Stocks Insights Pricing Resources

SystemsBoardsJournalsStocksInsightsPricingResourcesMore

Johnson & Johnson

$250.61

+0.72%

N/A+$1.79

Healthcare

Drug Manufacturers - General

NYSE

Active Trading

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. ...

CEO Profile Overview Fundamental Analysis Key Metrics Price Action Financial Highlights Financial Statements Leadership Team Earnings Call Transcripts Recent News Employee Count Key Products Supply Chain Insider Transactions

CEO Profile of JNJ

JNJ

Generating AI CEO profile...

Key Risk

No major risk extracted yet.

Key Tailwind

No major tailwind extracted yet.

About Us•Privacy Policy•Terms of Service•Join our Slack

© Plutux Technology Limited 2026